On the stock market since 2022, it operates in the world of money and finance. It has 49 employees. Now — the numbers.
The company is still in the product-building phase: its spending runs above its sales. That only changes once the product starts selling at scale.
Average growth of 21% a year over the last 4 years. Red columns mark years that ended in a loss.
Before the clock runs out, either sales must climb sharply or new money must come in. For now, time is on the company’s side.
Executives buying with their own money is usually read as confidence in the company’s future.
We compared this company with its own sector across five subjects.
A score of 50 means class average.
Clearly below the class average.
For a bank, strength is measured by capital buffers and reserves — not cash minus debt.
The price isn’t cheap next to earnings — that’s why this grade sits in the middle.
Clearly above the class average — a step short of the very top.
The stock has been running stronger than the market lately.
Financial Strength: The capital buffer looks thin next to its class; less room to absorb a rough stretch.
Business Quality: Profit power and business quality trail similar companies in the sector.
The stock trades near its peak today. For long-term holders the ride has paid off so far — though past performance guarantees nothing about the future.
Over the last 3 years, sales grew about 21% a year on average.
Sales run at $13.3M a year. A small number, but proof the product has real buyers.
Over the last 12 months, company executives reported 20 buys and 8 sells. Management buying with its own money is usually read as a good sign.
A loss of $386K against $13.3M in annual sales.
The balance sheet offers little cushion against a rough stretch. Report-card grade: 43/100.
Measured against its sector, the quality of the business sits below the class average. Report-card grade: 47/100.
On our five-subject report card, NSTS sits in the middle of the class: some subjects shine, others don’t. The grade moves as the numbers move.
The takeaway: NSTS is a high-risk stock — not yet profitable, and its future rides on its product catching on.